Large-scale clinical trials have demonstrated that GLP-1RAs predominantly exhibit neutral or suppressive effects on overall cancer risk, with semaglutide showing no elevated cancer incidence [14], while significant reductions have been observed in specific malignancies, particularly liver cancers and prostate cancers [13, 15]
Continuous use year-round at maintenance doses (0.5mg twice weekly) has been reported in research contexts for up to 24 months without tolerance development or cumulative adverse events beyond those seen in short-term protocols
Its unknown if the peptide can lead to acne, water retention, hair loss, headaches, fatigue, or lethargy
It acts as a structural scaffold, keeping skin firm, plump, and youthful
The ingredients were Sometimes the fitness industry is SO deceiving
Track T-cell activation and immune modulation Same Lumit platform as cytokine detection What about metabolic hormones and receptor signaling